<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>DOXOrubicin hydrochloride</title><link>http://www.unboundmedicine.com/medline/ebm/research/DOXOrubicin_hydrochloride</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Preclinical Evaluation of Linear HPMA-Doxorubicin Conjugates with pH-Sensitive Drug Release: Efficacy, Safety, and Immunomodulating Activity in Murine Model.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19894105/full_citation/Preclinical_Evaluation_of_Linear_HPMA_Doxorubicin_Conjugates_with_pH_Sensitive_Drug_Release:_Efficacy_Safety_and_Immunomodulating_Activity_in_Murine_Model_</link><description>Sirova M, Mrkvan T, Etrych T, et al. <br/><span class="title">Preclinical Evaluation of Linear HPMA-Doxorubicin Conjugates with pH-Sensitive Drug Release: Efficacy, Safety, and Immunomodulating Activity in Murine Model. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmaceutical research">Pharm Res 2009 Nov 6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19894105/abstract/Preclinical_Evaluation_of_Linear_HPMA_Doxorubicin_Conjugates_with_pH_Sensitive_Drug_Release:_Efficacy_Safety_and_Immunomodulating_Activity_in_Murine_Model_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19894105/full_citation/Preclinical_Evaluation_of_Linear_HPMA_Doxorubicin_Conjugates_with_pH_Sensitive_Drug_Release:_Efficacy_Safety_and_Immunomodulating_Activity_in_Murine_Model_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19894105/Preclinical_Evaluation_of_Linear_HPMA_Doxorubicin_Conjugates_with_pH_Sensitive_Drug_Release:_Efficacy_Safety_and_Immunomodulating_Activity_in_Murine_Model_">Find Related Articles</a> </description></item><item><title>Evaluation of the genotoxic and antigenotoxic effects after acute and subacute treatments with açai pulp (Euterpe oleracea Mart.) on mice using the erythrocytes micronucleus test and the comet assay.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19892033/full_citation/Evaluation_of_the_genotoxic_and_antigenotoxic_effects_after_acute_and_subacute_treatments_with_açai_pulp__Euterpe_oleracea_Mart___on_mice_using_the_erythrocytes_micronucleus_test_and_the_comet_assay_</link><description>Ribeiro JC, Antunes LM, Aissa AF, et al. <br/><span class="title">Evaluation of the genotoxic and antigenotoxic effects after acute and subacute treatments with açai pulp (Euterpe oleracea Mart.) on mice using the erythrocytes micronucleus test and the comet assay. [JOURNAL ARTICLE]</span><br/><span class="source" title="Mutation research">Mutat Res 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19892033/abstract/Evaluation_of_the_genotoxic_and_antigenotoxic_effects_after_acute_and_subacute_treatments_with_açai_pulp__Euterpe_oleracea_Mart___on_mice_using_the_erythrocytes_micronucleus_test_and_the_comet_assay_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19892033/full_citation/Evaluation_of_the_genotoxic_and_antigenotoxic_effects_after_acute_and_subacute_treatments_with_açai_pulp__Euterpe_oleracea_Mart___on_mice_using_the_erythrocytes_micronucleus_test_and_the_comet_assay_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S1383-5718(09)00367-2">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19892033/Evaluation_of_the_genotoxic_and_antigenotoxic_effects_after_acute_and_subacute_treatments_with_açai_pulp__Euterpe_oleracea_Mart___on_mice_using_the_erythrocytes_micronucleus_test_and_the_comet_assay_">Find Related Articles</a> </description></item><item><title>Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891724/full_citation/Feline_extranodal_lymphoma:_response_to_chemotherapy_and_survival_in_110_cats_</link><description>Taylor SS, Goodfellow MR, Browne WJ, et al. <br/><span class="title">Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="The Journal of small animal practice">J Small Anim Pract 2009 Nov; 50(11):584-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891724/abstract/Feline_extranodal_lymphoma:_response_to_chemotherapy_and_survival_in_110_cats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891724/full_citation/Feline_extranodal_lymphoma:_response_to_chemotherapy_and_survival_in_110_cats_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1748-5827.2009.00813.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19891724/Feline_extranodal_lymphoma:_response_to_chemotherapy_and_survival_in_110_cats_">Find Related Articles</a> </description></item><item><title>Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007)*.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891691/full_citation/Treatment_of_feline_mammary_tumours_using_chemotherapy_surgery_and_a_COX_2_inhibitor_drug__meloxicam_:_a_retrospective_study_of_23_cases__2002_2007___</link><description>Borrego JF, Cartagena JC, Engel J <br/><span class="title">Treatment of feline mammary tumours using chemotherapy, surgery and a COX-2 inhibitor drug (meloxicam): a retrospective study of 23 cases (2002-2007)*. [Journal Article]</span><br/><span class="source" title="Veterinary and comparative oncology">Vet Comp Oncol 2009 Dec; 7(4):213-21.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891691/abstract/Treatment_of_feline_mammary_tumours_using_chemotherapy_surgery_and_a_COX_2_inhibitor_drug__meloxicam_:_a_retrospective_study_of_23_cases__2002_2007___">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891691/full_citation/Treatment_of_feline_mammary_tumours_using_chemotherapy_surgery_and_a_COX_2_inhibitor_drug__meloxicam_:_a_retrospective_study_of_23_cases__2002_2007___">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19891691/Treatment_of_feline_mammary_tumours_using_chemotherapy_surgery_and_a_COX_2_inhibitor_drug__meloxicam_:_a_retrospective_study_of_23_cases__2002_2007___">Find Related Articles</a> </description></item><item><title>The role of cell death and myofibrillar damage in contractile dysfunction of long-term cultured adult cardiomyocytes exposed to doxorubicin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890731/full_citation/The_role_of_cell_death_and_myofibrillar_damage_in_contractile_dysfunction_of_long_term_cultured_adult_cardiomyocytes_exposed_to_doxorubicin_</link><description>Timolati F, Anliker T, Groppalli V, et al. <br/><span class="title">The role of cell death and myofibrillar damage in contractile dysfunction of long-term cultured adult cardiomyocytes exposed to doxorubicin. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cytotechnology">Cytotechnology 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890731/abstract/The_role_of_cell_death_and_myofibrillar_damage_in_contractile_dysfunction_of_long_term_cultured_adult_cardiomyocytes_exposed_to_doxorubicin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890731/full_citation/The_role_of_cell_death_and_myofibrillar_damage_in_contractile_dysfunction_of_long_term_cultured_adult_cardiomyocytes_exposed_to_doxorubicin_">Full Citation</a></description></item><item><title>Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890372/full_citation/Hsa_mir_125b_2_is_highly_expressed_in_childhood_ETV6/RUNX1__TEL/AML1__leukemias_and_confers_survival_advantage_to_growth_inhibitory_signals_independent_of_p53_</link><description>Gefen N, Binder V, Zaliova M, et al. <br/><span class="title">Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. [JOURNAL ARTICLE]</span><br/><span class="source" title="Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K">Leukemia 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890372/abstract/Hsa_mir_125b_2_is_highly_expressed_in_childhood_ETV6/RUNX1__TEL/AML1__leukemias_and_confers_survival_advantage_to_growth_inhibitory_signals_independent_of_p53_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890372/full_citation/Hsa_mir_125b_2_is_highly_expressed_in_childhood_ETV6/RUNX1__TEL/AML1__leukemias_and_confers_survival_advantage_to_growth_inhibitory_signals_independent_of_p53_">Full Citation</a></description></item><item><title>Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890356/full_citation/Protective_effect_of_tetrahydroxystilbene_glucoside_on_cardiotoxicity_induced_by_doxorubicin_in_vitro_and_in_vivo_</link><description>Zhang SH, Wang WQ, Wang JL <br/><span class="title">Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Acta pharmacologica Sinica">Acta Pharmacol Sin 2009 Nov; 30(11):1479-87.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890356/abstract/Protective_effect_of_tetrahydroxystilbene_glucoside_on_cardiotoxicity_induced_by_doxorubicin_in_vitro_and_in_vivo_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890356/full_citation/Protective_effect_of_tetrahydroxystilbene_glucoside_on_cardiotoxicity_induced_by_doxorubicin_in_vitro_and_in_vivo_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890356/Protective_effect_of_tetrahydroxystilbene_glucoside_on_cardiotoxicity_induced_by_doxorubicin_in_vitro_and_in_vivo_">Find Related Articles</a> </description></item><item><title>Oral Glutamine Protects against Acute Doxorubicin-Induced Cardiotoxicity of Tumor-Bearing Rats.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889810/full_citation/Oral_Glutamine_Protects_against_Acute_Doxorubicin_Induced_Cardiotoxicity_of_Tumor_Bearing_Rats_</link><description>Todorova VK, Kaufmann Y, Hennings L, et al. <br/><span class="title">Oral Glutamine Protects against Acute Doxorubicin-Induced Cardiotoxicity of Tumor-Bearing Rats. [JOURNAL ARTICLE]</span><br/><span class="source" title="The Journal of nutrition">J Nutr 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889810/abstract/Oral_Glutamine_Protects_against_Acute_Doxorubicin_Induced_Cardiotoxicity_of_Tumor_Bearing_Rats_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889810/full_citation/Oral_Glutamine_Protects_against_Acute_Doxorubicin_Induced_Cardiotoxicity_of_Tumor_Bearing_Rats_">Full Citation</a></description></item><item><title>Case Report: First Reported Case of Disease: Peliosis Hepatis as Cardinal Symptom of Hodgkin's Lymphoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889716/full_citation/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_</link><description>Kleger A, Bommer M, Kunze M, et al. <br/><span class="title">Case Report: First Reported Case of Disease: Peliosis Hepatis as Cardinal Symptom of Hodgkin's Lymphoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="The oncologist">Oncologist 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889716/abstract/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889716/full_citation/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889716/Case_Report:_First_Reported_Case_of_Disease:_Peliosis_Hepatis_as_Cardinal_Symptom_of_Hodgkin's_Lymphoma_">Find Related Articles</a> </description></item><item><title>Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889619/full_citation/Prognostic_significance_of_S_phase_kinase_associated_protein_2_and_p27kip1_in_patients_with_diffuse_large_B_cell_lymphoma:_effects_of_rituximab_</link><description>Seki R, Ohshima K, Fujisaki T, et al. <br/><span class="title">Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of oncology : official journal of the European Society for Medical Oncology / ESMO">Ann Oncol 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889619/abstract/Prognostic_significance_of_S_phase_kinase_associated_protein_2_and_p27kip1_in_patients_with_diffuse_large_B_cell_lymphoma:_effects_of_rituximab_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889619/full_citation/Prognostic_significance_of_S_phase_kinase_associated_protein_2_and_p27kip1_in_patients_with_diffuse_large_B_cell_lymphoma:_effects_of_rituximab_">Full Citation</a> | <a href="http://annonc.oxfordjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19889619">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889619/Prognostic_significance_of_S_phase_kinase_associated_protein_2_and_p27kip1_in_patients_with_diffuse_large_B_cell_lymphoma:_effects_of_rituximab_">Find Related Articles</a> </description></item></channel></rss>